EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing
(NASDAQ: EYPT) Delayed: 3.62 -0.03 (0.82%)
Previous Close $3.65    52 Week High $ 
Open $3.65    52 Week Low $ 
Day High $3.71    P/E N/A 
Day Low $3.56    EPS $ 
Volume 2,250,056